{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:57:02Z","timestamp":1787169422802,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacig.2025.100412","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T14:51:00Z","timestamp":1737211860000},"page":"100412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8459-3733","authenticated-orcid":false,"given":"Daiki","family":"Nakashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuguhisa","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Mitsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneya","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Haruna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Matsuwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100412_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jacig.2025.100412_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jacig.2025.100412_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.alit.2019.07.002","article-title":"Eosinophilic chronic rhinosinusitis","volume":"68","author":"Fujieda","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jacig.2025.100412_bib4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2022.10.010","article-title":"Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors","volume":"151","author":"Wang","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100412_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","article-title":"Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper","volume":"10","author":"Hox","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jacig.2025.100412_bib6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100412_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.anl.2010.11.016","article-title":"Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease","volume":"38","author":"Iino","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jacig.2025.100412_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4193\/Rhin17.156","article-title":"Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review","volume":"56","author":"Tsetsos","year":"2018","journal-title":"Rhinology"},{"key":"10.1016\/j.jacig.2025.100412_bib9","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","article-title":"Staging for rhinosinusitis","volume":"117","author":"Lund","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jacig.2025.100412_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.anl.2019.04.002","article-title":"Clinical practice guidelines for the management of olfactory dysfunction\u2014secondary publication","volume":"46","author":"Miwa","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jacig.2025.100412_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.anl.2012.02.007","article-title":"Evaluation of \"Open Essence\" odor-identification test card by application to healthy volunteers","volume":"40","author":"Okutani","year":"2013","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jacig.2025.100412_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.anl.2010.05.013","article-title":"Clinical availability of a self-administered odor questionnaire for patients with olfactory disorders","volume":"38","author":"Takebayashi","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jacig.2025.100412_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely-available easy-to-use software \u201cEZR\u201d (Easy R) for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jacig.2025.100412_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.alit.2023.03.007","article-title":"Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis","volume":"72","author":"Nakashima","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.jacig.2025.100412_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12890-022-02046-3","article-title":"Real- life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP","volume":"22","author":"Minagawa","year":"2022","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jacig.2025.100412_bib16","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2025.100412_bib17","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/jpm12101734","article-title":"Proposal for a structured outpatient clinic for dupilumab treatment in chronic rhinosinusitis with nasal polyps in the first year of treatment","volume":"12","author":"Torretta","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jacig.2025.100412_bib18","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/jcm11102684","article-title":"Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a \"real-life\" observational study in the first year of treatment","volume":"11","author":"De Corso","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacig.2025.100412_bib19","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/all.15796","article-title":"Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months","volume":"78","author":"van der Lans","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100412_bib20","first-page":"194","article-title":"EPOS\/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"key":"10.1016\/j.jacig.2025.100412_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.anl.2011.09.001","article-title":"Impact of residual ethmoid cells on postoperative course after endoscopic sinus surgery for chronic rhinosinusitis","volume":"39","author":"Okushi","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jacig.2025.100412_bib22","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00405-018-5003-7","article-title":"Impact of residual frontal recess cells on frontal sinusitis after endoscopic sinus surgery","volume":"275","author":"Nakayama","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jacig.2025.100412_bib23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00405-022-07679-y","article-title":"Dupilumab (Dupixent\u00ae) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany","volume":"280","author":"Jansen","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jacig.2025.100412_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100780","article-title":"Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy","volume":"16","author":"Albrecht","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2025.100412_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MED.0000000000000804","article-title":"Glucocorticoid withdrawal syndrome: what to expect and how to manage","volume":"30","author":"Theiler-Schwetz","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jacig.2025.100412_bib26","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jaip.2022.05.019","article-title":"Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis","volume":"10","author":"Wechsler","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"Suppl 2","key":"10.1016\/j.jacig.2025.100412_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000350387","article-title":"Total and antigen- (fungi, mites and staphylococcal enterotoxins) specific IgEs in nasal polyps is related to local eosinophilic inflammation","volume":"161","author":"Matsuwaki","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jacig.2025.100412_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/19458924231204128","article-title":"Long-term efficacy of dupilumab for eosinophilic chronic rhinosinusitis","volume":"38","author":"Tsunemi","year":"2024","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jacig.2025.100412_bib29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacig.2025.100412_bib30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4049\/jimmunol.2200294","article-title":"Androgens alleviate allergic airway inflammation by suppressing cytokine production in Th2 cells","volume":"209","author":"Ejima","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.jacig.2025.100412_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.anai.2020.08.001","article-title":"Group 2 innate lymphoid cells in nasal polyposis","volume":"126","author":"Stevens","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2025.100412_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imr.12706","article-title":"The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms","volume":"286","author":"Kabata","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jacig.2025.100412_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/all.14491","article-title":"Estrogen receptor-\u03b1 signaling increases allergen-induced IL-33 release and airway inflammation","volume":"76","author":"Cephus","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100412_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaci.2021.04.029","article-title":"Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1","volume":"149","author":"Blanquart","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100412_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/iid3.46","article-title":"A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men","volume":"3","author":"Stevens","year":"2015","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jacig.2025.100412_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.anl.2023.09.007","article-title":"Clinical characteristics in Japanese patients with chronic rhinosinusitis who underwent endoscopic sinus surgery","volume":"51","author":"Inoue","year":"2023","journal-title":"Auris Nasus Larynx"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277282932500013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277282932500013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:20:50Z","timestamp":1762647650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277282932500013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S277282932500013X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100412","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100412"}}